← FDA DRUG APPROVALS

FDA ANDA · ANDA205702

TRAMADOL HYDROCHLORIDE

Sponsor: MACLEODS PHARMS LTD

APPLICATION
ANDA205702
TYPE
ANDA
ORIGINAL APPROVAL
2015-09-25
LATEST ACTION
2026-06-18
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

TRAMADOL HYDROCHLORIDEDiscontinued
TRAMADOL HYDROCHLORIDE 50MG · TABLET · ORAL

Approval history

2026-06-18REMS · Supplement 33AP
2025-12-29Labeling · Supplement 32 · standardAP
2025-05-06Labeling · Supplement 28 · standardAP
2024-10-31REMS · Supplement 29AP
2023-12-15Labeling · Supplement 27 · standardAP
2023-12-15Labeling · Supplement 25 · standardAP
2023-10-19Labeling · Supplement 23 · standardAP
2023-10-19Labeling · Supplement 15 · standardAP
2023-10-19Labeling · Supplement 2 · standardAP
2023-10-19Labeling · Supplement 12 · standardAP
2023-10-19Labeling · Supplement 10 · standardAP
2023-10-19Labeling · Supplement 19 · standardAP
2023-06-07Labeling · Supplement 22 · standardAP
2018-09-18REMS · Supplement 7AP
2015-09-25UNKNOWN · Original · standardREMSAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →